Unique ID issued by UMIN | UMIN000035781 |
---|---|
Receipt number | R000040696 |
Scientific Title | A randomized phase II study of robot-assisted thoracoscopic versus thoracoscopic esophagectomy for patients with curative surgery for thoracic esophageal cancer |
Date of disclosure of the study information | 2019/02/15 |
Last modified on | 2019/02/15 00:28:03 |
A randomized phase II study of robot-assisted thoracoscopic versus thoracoscopic esophagectomy for patients with curative surgery for thoracic esophageal cancer
RATE for TEC
A randomized phase II study of robot-assisted thoracoscopic versus thoracoscopic esophagectomy for patients with curative surgery for thoracic esophageal cancer
RATE for TEC
Japan |
Thoracic esophageal cancer
Gastrointestinal surgery |
Malignancy
NO
To examine the safety of robot assisted thoracoscopic esophagectomy compared with thoracoscopic esophagectomy.
Safety
Exploratory
Pragmatic
Phase II
Incidence of Grade I or more postoperative recurrent nerve paralysis in Clavien-Dindo classification
1) Grade II and more total complications in Clavien-Dindo classification, 2) Operation time, 3) Blood loss, 4) Number of dissected mediastinum lymph node, 5) Change of surgical method, 6) Intraoperative adverse event, 7) Postoperative hospital stay , 8) QOL score (EORTC QLQ-C30, EORTC QLQ-OES18, EQ-5D-5L), 9) Operation related death, 10) Recurrent free survival
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Device,equipment | Maneuver |
Thoracoscopic esophagectomy for thoracic esophageal cancer
Robot assisted thoracoscopic esophagectomy for thoracic esophageal cancer
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Primary lesions are all confined within the thoracic esophagus, 2) an esophageal epithelial malignancy, 3) Clinical stage I,II,III(excluding T4), UICC-TNM 8th, 4) Surgery approached from the neck, chest and abdomen (R0 resection) with D2 dissection followed by gastric conduit reconstruction, 5) >20 and <80 y.o., 6) ECOG-PS 0 or 1, 7) BMI >17 and <30, 8) No history of surgery for esophageal cancer, 9 ) No history of chemotherapy or radiotherapy, 10) No history of right thoracotomy or left lung lobectomy, 11) FEV1.0 >1.0L, 12) a) WBC >2000 and <10000/mm3, b) PLT >50000/mm3, c) Hb >10.0 g/dl, d) AST <100 IU/L, ALT <100IU/L, e) T-Bil <2.0 g/dl, f) Cre <1.5mg/dl, g) SpO2 >95%, 13) Written consent
1) Excision of other organs excluding gall bladder, 2) Active double cancer, 3) Pregnancy or breast-feeding, 4) Psychosis or mental symptoms, 5) Systemic administration of steroids, 6) History of myocardial infarction or unstable angina, 7) Poorly controlled hypertension, 8) Poorly controlled diabetes, 9) Respiratory disease requiring sustained oxygen therapy.
70
1st name | |
Middle name | |
Last name | Takashi Kamei |
Tohoku University Hospital
Department of Surgery
1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN
022-717-7214
tkamei@med.tohoku.ac.jp
1st name | |
Middle name | |
Last name | Hiroshi Okamoto |
Tohoku University Hospital
Department of Surgery
1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN
022-717-7214
hi-ok-0531@med.tohoku.ac.jp
Tohoku University Hospital
University grants of Tohoku University Hospital
Self funding
NO
東北大学病院(宮城県)
2019 | Year | 02 | Month | 15 | Day |
Unpublished
Enrolling by invitation
2019 | Year | 01 | Month | 29 | Day |
2019 | Year | 03 | Month | 01 | Day |
2019 | Year | 02 | Month | 05 | Day |
2019 | Year | 02 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040696
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |